|
Estimated five-year commitment in US$ to 70 countries (July 2004)
Country |
Surviving Infants at first approval |
DTP3 coverage at first approval |
5 years Immunization Services Support |
3 years Injection safety support |
5 years New and Under-used vaccine Support |
Vaccine presentation |
Other support |
Total commitment for five years |
Afghanistan |
901,328 |
31% |
7,255,000 |
1,619,000 |
|
|
|
8,874,000 |
Albania |
60,000 |
93% |
|
102,000 |
352,000 |
hepB |
100,000 |
554,000 |
Angola |
623,114 |
50% |
6,565,000 |
1,525,000 |
|
|
|
8,090,000 |
Armenia |
36,118 |
63% |
60,000 |
54,500 |
337,000 |
hepB |
100,000 |
551,500 |
Azerbaijan |
106,250 |
72% |
487,500 |
145,000 |
679,500 |
hepB |
100,000 |
1,412,000 |
Bangladesh |
3,662,915 |
67% |
26,935,500 |
8,204,500 |
16,436,500 |
hepB |
100,000 |
51,676,500 |
Benin |
240,517 |
61% |
|
415,000 |
20,280,000 |
YF & hepB, to DTP-HepB+Hib in 2005 |
100,000 |
20,795,000 |
Bhutan |
15,902 |
88% |
|
29,000 |
390,000 |
DTP-hepB 2003 |
100,000 |
519,000 |
Bolivia |
202,677 |
93% |
|
665,000 |
|
|
|
665,000 |
Bosnia & Herz |
39,633 |
85% |
|
|
259,500 |
hepB |
100,000 |
359,500 |
Burkina Faso |
456,000 |
42% |
4,410,500 |
834,500 |
|
|
|
5,245,000 |
Burundi |
261,669 |
57% |
2,662,500 |
428,000 |
18,730,000 |
DTP-Hib & hepB (2004); then DTP-hepB+Hib |
100,000 |
21,920,500 |
Cambodia |
434,774 |
65% |
3,012,500 |
667,500 |
6,029,000 |
DTP-hepB |
100,000 |
9,809,000 |
Cameroon |
594,855 |
48% |
5,557,000 |
1,108,500 |
8,383,000 |
YF, hepB |
100,000 |
15,148,500 |
CAR |
131,612 |
23% |
1,837,000 |
156,000 |
630,000 |
YF |
100,000 |
2,723,000 |
Chad |
287,769 |
32% |
2,715,000 |
421,500 |
1,151,500 |
YF |
100,000 |
4,388,000 |
China |
19,107,468 |
93% |
|
15,926,000 |
21,953,500 |
hepB |
800,000 |
38,679,500 |
Comoros |
21,376 |
67% |
173,500 |
37,000 |
135,500 |
hepB |
100,000 |
446,000 |
Congo Rep |
141,266 |
50% |
1,534,500 |
266,500 |
796,500 |
YF |
100,000 |
2,697,500 |
Congo DRC |
2,425,327 |
31% |
31,298,500 |
3,238,000 |
11,594,000 |
YF |
100,000 |
46,230,500 |
Côte d’Ivoire |
468,276 |
56% |
3,859,500 |
|
7,957,500 |
DTP-hepB |
100,000 |
11,917,000 |
Djibouti |
24,762 |
53% |
271,000 |
32,000 |
|
|
|
303,000 |
Eritrea |
97,846 |
61% |
930,500 |
147,000 |
2,088,500 |
DTP-hepB |
100,000 |
3,266,000 |
Ethiopia |
2,532,519 |
45% |
19,130,000 |
3,091,000 |
|
|
|
22,221,000 |
Gambia |
51,840 |
74% |
489,500 |
109,000 |
3,287,000 |
hepB & DTP-Hib & Hib |
100,000 |
3,985,500 |
Georgia |
50,776 |
61% |
341,000 |
60,000 |
600,500 |
hepB |
100,000 |
1,101,500 |
Ghana |
779,359 |
73% |
2,888,000 |
824,500 |
44,021,000 |
DTP-hepB+Hib & YF |
100,000 |
47,833,500 |
Guinea |
288,702 |
57% |
2,585,500 |
645,500 |
1,012,000 |
YF |
100,000 |
4,343,000 |
Guinea Bissau |
43,500 |
47% |
423,000 |
123,500 |
|
|
|
546,500 |
Guyana |
20,414 |
83% |
|
|
1,017,500 |
DTP-hepB+Hib |
100,000 |
1,117,500 |
Haiti |
262,500 |
59% |
2,171,000 |
494,000 |
|
hepB |
|
2,665,000 |
Honduras |
187,704 |
98% |
|
471,500 |
|
|
|
471,500 |
India |
24,460,000 |
55% |
|
|
4,124,000 |
hepB (2002 & 2003 only) |
100,000 |
4,224,000 |
Indonesia |
4,570,828 |
90% |
15,328,000 |
9,707,000 |
14,865,000 |
hepB Uniject |
100,000 |
40,000,000 |
Kenya |
1,285,300 |
64% |
11,113,500 |
1,220,000 |
64,883,500 |
DTP-hepB+Hib & YF |
100,000 |
77,317,000 |
Korea DPR |
441,096 |
63% |
3,315,500 |
761,000 |
2,465,000 |
hepB |
100,000 |
6,641,500 |
Kyrgyz Rep |
98,637 |
99% |
|
178,000 |
1,123,000 |
hepB |
100,000 |
1,401,000 |
Lao PDR |
180,000 |
56% |
2,251,500 |
279,000 |
3,394,500 |
DTP-hepB |
100,000 |
6,025,000 |
Lesotho |
64,324 |
56% |
517,500 |
110,500 |
382,500 |
hepB |
100,000 |
1,110,500 |
Liberia |
147,540 |
23% |
2,405,000 |
|
533,500 |
YF |
100,000 |
3,038,500 |
Madagascar |
588,315 |
57% |
4,277,500 |
|
13,701,000 |
DTP-hepB |
100,000 |
18,079,000 |
Malawi |
393,539 |
83% |
|
|
32,486,000 |
DTP-hepB+Hib |
100,000 |
32,586,000 |
Mali |
391,620 |
45% |
4,426,000 |
780,500 |
3,167,500 |
hepB & YF |
100,000 |
8,474,000 |
Mauritania |
106,768 |
61% |
1,062,000 |
201,000 |
825,000 |
hepB |
100,000 |
2,188,000 |
Moldova |
41,100 |
98% |
|
|
342,000 |
hepB |
100,000 |
442,000 |
Mongolia |
43,700 |
98% |
|
109,000 |
3,235,000 |
phased DTP-hepB+Hib |
100,000 |
3,444,000 |
Mozambique |
672,000 |
73% |
3,291,000 |
986,000 |
15,875,500 |
DTP-hepB |
100,000 |
20,252,500 |
Myanmar |
1,271,239 |
70% |
7,902,500 |
1,343,000 |
15,178,500 |
hepB |
100,000 |
24,524,000 |
Nepal |
727,764 |
72% |
4,494,000 |
1,369,500 |
3,651,500 |
hepB |
100,000 |
9,615,000 |
Niger |
484,000 |
23% |
5,027,000 |
1,012,000 |
|
YF |
|
6,039,000 |
Nigeria |
4,608,972 |
38% |
53,020,000 |
|
27,167,500 |
YF |
100,000 |
80,849,500 |
Pakistan |
4,878,000 |
58% |
32,508,000 |
9,521,500 |
26,200,000 |
hepB |
100,000 |
68,329,500 |
Rwanda |
326,886 |
57% |
3,728,000 |
406,000 |
21,413,000 |
DTP-hepB+Hib |
100,000 |
25,647,000 |
São Tome |
5,651 |
79% |
65,500 |
11,500 |
66,000 |
hepB; YF |
100,000 |
243,000 |
Senegal |
418,091 |
52% |
3,983,500 |
749,500 |
21,338,000 |
hepB; Hib |
100,000 |
26,171,000 |
Sierra Leone |
166,464 |
39% |
2,424,500 |
312,500 |
1,369,500 |
YF |
100,000 |
4,210,500 |
Somalia |
270,769 |
30% |
3,399,500 |
349,000 |
|
|
|
3,748,500 |
Sri Lanka |
322,366 |
99% |
|
622,500 |
2,356,000 |
hepB |
100,000 |
3,078,500 |
Sudan |
1,029,179 |
64% |
8,968,500 |
1,828,000 |
4,701,000 |
hep B |
100,000 |
15,597,500 |
Tajikistan |
155,283 |
65% |
1,510,500 |
255,500 |
859,000 |
hepB |
100,000 |
2,725,000 |
Tanzania |
1,279,401 |
74% |
8,665,500 |
1,510,000 |
30,078,000 |
DTP-hepB |
100,000 |
40,353,500 |
Togo |
196,240 |
43% |
1,945,500 |
374,500 |
935,500 |
YF |
100,000 |
3,355,500 |
Turkmenistan |
94,818 |
96% |
|
171,000 |
809,000 |
hepB |
100,000 |
1,080,000 |
Uganda |
968,155 |
54% |
11,794,500 |
1,338,000 |
74,213,000 |
DTP-hepB+Hib |
100,000 |
87,445,500 |
Ukraine |
395,196 |
97% |
|
747,500 |
2,228,000 |
hepB |
100,000 |
3,135,500 |
Uzbekistan |
533,484 |
95% |
|
809,500 |
3,618,500 |
hepB |
100,000 |
4,528,000 |
Viet Nam |
1,577,046 |
93% |
|
3,296,500 |
11,550,000 |
hepB |
100,000 |
14,946,500 |
Yemen |
592,436 |
73% |
4,342,000 |
1,238,000 |
43,919,500 |
DTP-hepB+Hib |
100,000 |
49,599,500 |
Zambia |
427,524 |
75% |
2,959,500 |
762,500 |
33,491,000 |
DTP-Hib (2004); then DTP-hepB+Hib |
100,000 |
37,313,000 |
Zimbabwe |
380,394 |
78% |
3,220,000 |
1,319,000 |
|
hepB; Hib |
|
4,539,000 |
TOTAL |
89,152,893 |
|
336,572,500 |
85,519,500 |
654,260,500 |
|
6,500,000 |
1,082,852,500 |
|
|